Change Path »

Summit Therapeutics shares owned by Change Path

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Change Path from 13F filings

Historical chart of Change Path investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Change Path consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Change Path

Quarter filed Position value Share count Share price at filing
2024-09-30 $442k 20k 21.90
2024-06-30 $90k 12k 7.76

More positions owned by Change Path

Ishares Tr Core Total Usd (IUSB)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Advisorshares Tr Star Glob Buyw (VEGA)
Ishares Tr S&p 500 Grwt Etf (IVW)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Microsoft Corporation (MSFT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)

View all positions for Change Path

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
BlackRock
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Jane Street
Susquehanna International
Citadel Advisors
Charles Schwab Investment Management
Standard Life Aberdeen
Darwin Global Management
Balyasny Asset Management
Northern Trust

View all funds holding Summit Therapeutics